SEARCH

SEARCH BY CITATION

REFERENCES

  • Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJ, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D. 2010. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 86: 551559.
  • Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC. 2006. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. New Engl J Med 355: 27572764.
  • Bauze RJ, Smith R, Francis MJ. 1975. A new look at osteogenesis imperfecta. A clinical, Radiological and biochemical study of forty-two patients. J Bone Joint Surg Br 57: 212.
  • Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman J, Hoischen A, Netzer C. 2011. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88: 362371.
  • Ben Amor M, Francis H, Glorieux FH, Rauch F. 2011. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos 2011: 540178.
  • Byers PH, Steiner RD. 1992. Osteogenesis imperfecta. Annu Rev Med 43: 269282.
  • Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC. 2007. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39: 359365 (Erratum: Nat Genet. 40: 927, 2008).
  • Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, AlBalwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH. 2010. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86: 389398.
  • Dixon WJ, Massey JFJ. 1983. In: Dixon WJ, Massey JFJ, editors. Introduction to statistical analysis 4th edition. International Student Edition. New York, USA: McGraw-Hill, International Book Company.
  • Drögemüller C, Becker D, Brunner A, Haase B, Kircher P, Seeliger F, Fehr M, Baumann U, Lindblad-Toh K, Leeb T. 2009. A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta. PLoS Genet 5: e1000579.
  • El-Houssini RM. 2009. A genetic study of osteogenesis imperfecta. MSc. Thesis in Pediatrics. Faculty of Medicine, Cairo University.
  • Falvo KA, Leon Root, Bullough PG. 1974. Osteogenesis imperfecta: Clinical evaluation and management. J Bone Joint Surg Am 56: 783793.
  • Ghalli I, Salah N, Hussien F, Erfan M, El-Ruby M, Mazen I, Aglan MS, Hosny L, Zaki M, Ismail S, Elgammal M, Abd El-Dayem S., et al. In: Sartorio A, Buckler JMH, Marazzi N, editors. Proceedings of the 1st National Congress for Egyptian Growth Curves, Cairo University, 11 December 2003, Cairo. Published in Cresceve Nelmondo (2008). Ferring Company. Egyptian Growth Curves 2002 for Infants, Children and Adolescents.
  • Goldman AB, Davidson D, Pavlov H, Bullough PG. 1980. Popcorn calcifications: A prognostic sign in osteogenesis imperfecta. Radiology 136: 351358.
  • Hall JG, Foster-Iskenius UC, Allanson JE. 1989. Handbook of normal physical measurements. UK: Oxford Medical Publications.
  • Hanscom DA, Winter RB, Lutter L, Lonstein JE, Bloom BA, Bradford DS. 1992. Osteogenesis imperfecta. Radiographic classification, natural history and treatment of spinal deformities. J Bone Joint Surg Am 74: 598616.
  • Hiernaux J, Tanner JM. 1969. Growth and physical studies. In: Weiner JS, Lourie SA, editors. Human biology: A guide to field methods. London: Blackwell Scientific Publications.
  • Lapunzina P, Aglan M, Temtamy S, Caparrós-Martín JA, Valencia M, Letón R, Martínez-Glez V, Elhossini R, Amr K, Vilaboa N, Ruiz-Perez VL. 2010. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 87: 110114.
  • Lund AM, Müller J, Skovby F. 1999. Anthropometry of patients with osteogenesis imperfecta. Arch Dis Child 80: 524528.
  • Marini JC, Bordenick S, Heavner G, Rose S, Chrousos GP. 1993. Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta. Am J Med Genet 45: 261264.
  • Marini JC, Bordenick S, Heavner G, Rose S, Hintz R, Rosenfeld R, Chrousos GP. 1993. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J Clin Endocrinol Metab 76: 251256.
  • Martínez-Glez V, Valencia M, Caparrós-Martín JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL. 2012. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33: 343350.
  • Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B. 2006. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127: 291304.
  • National Institutes of Health Clinical Center. 2007. Growth hormone therapy in osteogenesis imperfecta. Rockville Pike: National Institutes of Health Clinical Center. prpl@mail.cc.nih.gov
  • Plotkin H. 2004. Syndromes with congenital brittle bones. BMC Pediatr 4: 16.
  • Rauche F, Lalic L, Roughley P, Glorieux FH. 2010a. Genotype–phenotype correlations in nonlethal osteogenesis imperfect caused by mutations in the helical domain of collagen type I. Eur J Hum Genet 18: 642647.
  • Rauche F, Lalic L, Roughley P, Glorieux FH. 2010b. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25: 13671374.
  • Sillence DO, Senn A, Danks DM. 1979. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16: 101116.
  • Tanner JM. 1984. Auxological methods in the differential diagnosis of short stature. Annales Nestlé 41: 3.
  • UnderWood EL, Vanwyk JJ. 1981. Hormones in normal and abarrent growth. In: Williams RE, editor. Text book of endocrinology, EDN 6th edition. Philadelphia, Pennsylvania: Saunders WB, Publishers.
  • van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PGJ, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, van Roij MHH, Elting MW, Verbeke JI, Wijnaendts LC, Shaw NJ, Högler W, McKeown C, Sistermans EA, Dalton A, Meijers-Heijboer H, Pals G. 2009. PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 85: 521527.
  • Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A. 2011. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet Part A 155A: 943968.
  • Zeitlin L, Rauch F, Horacio Plotkin H, Glorieux FH. 2003. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111: 10301036.